Grown Rogue Reports Strong Preliminary 2025 Results, Reschedules Full Release for IFRS to GAAP Transition
Summary
Grown Rogue reported strong preliminary 2025 financial results with significant revenue growth and a net income turnaround, though the full audited release is delayed due to an IFRS to U.S. GAAP accounting transition.
Key Events
-
Preliminary 2025 Financial Results
Reported preliminary, unaudited 2025 revenue of $32.4 million (up 22% YoY), net income of $2.4 million (vs. a $16.1 million loss in 2024), and Adjusted EBITDA of $5.3 million (up 39% YoY).
-
Rescheduled Full Results Release
The release of full audited 2025 financial results and the related conference call have been rescheduled to April 7, 2026.
-
Reason for Delay
The delay is attributed to additional time needed to complete year-end financial reporting and review procedures, specifically related to the transition from International Financial Reporting Standards (IFRS) to U.S. Generally Accepted Accounting Principles (U.S. GAAP) as a U.S. domestic issuer. The company noted no material deficiencies or disagreements with auditors.
-
Strong Cash Position
Cash and cash equivalents increased by 133% to $11.4 million as of December 31, 2025.
Analysis
Grown Rogue International Inc. announced robust preliminary, unaudited financial results for 2025, showcasing significant growth in revenue, a turnaround to positive net income, and a substantial increase in Adjusted EBITDA and cash. While the full audited results and conference call have been rescheduled to April 7, 2026, due to complexities in transitioning from IFRS to U.S. GAAP, the company emphasized that the delay is administrative and not due to auditor disagreements or undisclosed material information. This strong preliminary performance, despite the minor administrative delay, suggests operational improvements and a healthier financial position.
At the time of this filing, GRUSF was trading at $0.30 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $75.7M. The 52-week trading range was $0.27 to $0.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.